About
Precigen is a commercial-stage biopharmaceutical company specializing in developing precision medicines using gene and cell therapy technologies to treat difficult-to-treat diseases with high unmet patient needs.
Explore Precigen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.